Question

In the graph to the right:
Trial A (no immunity) is the
line. Trial B (25% immune) is the
line. Trial C (50% immune) is the
line.

Post-Lab Reflection

Answer 1

I can’t see the graph you mention. Please either upload the image or tell me the line styles/colors (for example “red solid, blue dashed, green dotted”) so I can label each trial exactly.

Meanwhile, here’s how to identify which curve is which and some language you can use in your Post‑Lab Reflection:

How to tell the curves apart
- No immunity (Trial A) will have the fastest, highest outbreak: earliest and largest peak because every contact is susceptible.
- 25% immune (Trial B) will show a lower peak and a slower rise than Trial A, but higher than 50% immune.
- 50% immune (Trial C) will be the lowest and most flattened curve, often delayed in time and with the smallest peak and fewer total infections.

Example fill‑ins (if the graph uses color or line style)
- Trial A (no immunity) is the [red solid] line (highest/earliest peak).
- Trial B (25% immune) is the [blue dashed] line (intermediate peak).
- Trial C (50% immune) is the [green dotted] line (lowest/most flattened).

Points to include in your Post‑Lab Reflection
- Observations: compare peak height, time to peak, and overall area under each curve (total infected).
- Explanation: higher initial immunity reduces the susceptible pool, so transmission chains die out faster and the epidemic peak is lower and later.
- Public‑health implication: partial immunity flattens the curve and reduces healthcare burden; higher immunity moves the population toward herd immunity.
- Limitations: model assumptions (homogeneous mixing, constant contact rate, no births/deaths, perfect immunity) and stochastic effects in small populations.
- Possible extensions: vary R0, vaccination timing, or include age structure and contact networks.

If you upload the graph or tell me the line colors/styles, I will label them precisely and can draft a short reflection paragraph you can use.